03/12/2025
BioMatrix Healthcare marks another significant regulatory milestone!
Our dossier for Mycophenolate Mofetil Tablets 500 mg has been successfully submitted in the EU via DCP.
This essential immunosuppressant plays a vital role in improving the lives of organ transplant patients worldwide.
Advancing global healthcare, one submission at a time.